INKT · ISSUER CIK 1840229
MiNK Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 6 MiNK Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $73K of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$73KInsider selling
−$73KNet open-market
Oct 14, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 202614:36 | Oct 12, 2026 | INKT | Chief Executive Officer, Director | S · Sell | $10.56 | −6,938 | 74,195 | -9% | −$73K | ||
| Oct 14, 202614:36 | Oct 11, 2026 | INKT | Chief Executive Officer, Director | M · Exercise | — | +23,191 | 81,133 | +40% | — | ||
| Sep 2, 202611:10 | Sep 1, 2026 | INKT | Director | A · Grant | $10.95 | +1,279 | 23,929 | +6% | $14K | ||
| Sep 2, 202610:21 | Sep 1, 2026 | INKT | Director | A · Grant | $10.95 | +1,233 | 4,691 | +36% | $14K | ||
| Sep 2, 202610:20 | Sep 1, 2026 | INKT | Director | A · Grant | $10.95 | +1,485 | 24,404 | +6% | $16K | ||
| Sep 2, 202610:19 | Sep 1, 2026 | INKT | Director | A · Grant | $10.95 | +1,622 | 23,591 | +7% | $18K | ||
| Sep 2, 202610:16 | Sep 1, 2026 | INKT | Director | A · Grant | $10.95 | +1,633 | 54,770 | +3% | $18K |